Senior Health Home > Menomune Vaccine Information

Menomune® (meningococcal vaccine) is approved for the prevention of invasive meningococcal diseases, such as:
  • Bloodstream infections
  • Bacterial meningitis (a bacterial infection of the fluid surrounding the brain and spinal cord).
This vaccine works by "tricking" the body into thinking it has been exposed to Neisseria meningitidis bacteria, but without actually risking infection. It is usually given as a single injection in the upper arm. Menomune is approved for people over the age of 2, and is currently the only meningococcal vaccine in the United States that is approved for use in people over the age of 55.
This product may not be suitable for everyone. For example, Menomune vials contain dry natural latex rubber, which could cause problems for people with latex allergies. Before getting vaccinated, tell your healthcare provider if you are allergic to latex or have any allergies to foods, dyes, or preservatives. Common side effects include pain or redness at the injection site, fatigue, and a general ill feeling.
(For more information on this vaccine, click Menomune. This article takes an in-depth look at topics such as whether Menomune is available as a generic, when and how to get vaccinated, whether the vaccine contains aluminum, and more.)
Written by/reviewed by:
Last reviewed by: Arthur Schoenstadt, MD
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation

Topics & Medications


Related Channels

eMedTV Links
Copyright © 2006-2020 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.